Your browser doesn't support javascript.
loading
A TLR4 Agonist Induces Osteosarcoma Regression by Inducing an Antitumor Immune Response and Reprogramming M2 Macrophages to M1 Macrophages.
Richert, Iseulys; Berchard, Paul; Abbes, Lhorra; Novikov, Alexey; Chettab, Kamel; Vandermoeten, Alexandra; Dumontet, Charles; Karanian, Marie; Kerzerho, Jerome; Caroff, Martine; Blay, Jean-Yves; Dutour, Aurélie.
Afiliação
  • Richert I; Cell Death and Pediatric Cancers Team INSERM U1052, CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, Université de Lyon, 69373 Lyon, France.
  • Berchard P; Cell Death and Pediatric Cancers Team INSERM U1052, CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, Université de Lyon, 69373 Lyon, France.
  • Abbes L; Cell Death and Pediatric Cancers Team INSERM U1052, CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, Université de Lyon, 69373 Lyon, France.
  • Novikov A; HEPHAISTOS-Pharma, 21 rue Jean Rostand, 91400 Orsay, France.
  • Chettab K; INSERM U1052, CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, Université de Lyon, 69373 Lyon, France.
  • Vandermoeten A; Hospices Civils de Lyon, 69007 Lyon, France.
  • Dumontet C; SCAR, Rockefeller Medecine School, Université Claude Bernard Lyon 1, 69367 Lyon, France.
  • Karanian M; INSERM U1052, CNRS UMR 5286, Centre de Recherche en Cancérologie de Lyon, Université de Lyon, 69373 Lyon, France.
  • Kerzerho J; Hospices Civils de Lyon, 69007 Lyon, France.
  • Caroff M; Department of Biopathology, Léon Bérard Center, Unicancer, 69008 Lyon, France.
  • Blay JY; HEPHAISTOS-Pharma, 21 rue Jean Rostand, 91400 Orsay, France.
  • Dutour A; HEPHAISTOS-Pharma, 21 rue Jean Rostand, 91400 Orsay, France.
Cancers (Basel) ; 15(18)2023 Sep 19.
Article em En | MEDLINE | ID: mdl-37760603

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2023 Tipo de documento: Article País de afiliação: França